-
Conditions
Interventions
Control group,
no intervention. Blood parameters and other physical measurements taken at the baseline and end of the experiment,Baseline blood and physical parameters measurements and then at the end of the experim
no chia seeds consumption,Chia seeds consumption
Sponsors
Kuwait University
Eligibility
Sex/Gender
All
Age
21 Years to 65 Years
Inclusion criteria
Inclusion criteria: - T2DM patients age (21-65) years - Stable renal function in the last 6 months prior to the study. - Stable dose of medication for the past 3 months. - Female of childbearing age must have effective contraceptive during the trial. - Patients on oral hypoglycemic agents and a single insulin dose (basal insulin).
Exclusion criteria
Exclusion criteria: - Those have intolerance or allergy to the product. - Pregnant women. - Patients with end-stage complications. - Multiple insulin dosage. - Newly diagnosed Type 2 Diabetes. - Patients taking Aspirin and warfarin to avoid any possible interaction or thinning effect from n-3 PUFA in the chia seeds.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycated Hemoglobin, Fasting blood Glucose and Insulin baseline and end of experiment, 12 weeks blood tests for fasting glucose insulin and HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure and Plasma Lipids Baseline and end of experiment, 12 weeks routine lab procedures | — |
Countries
Kuwait
Contacts
Public ContactTasleem Zafar
Kuwait University
Outcome results
None listed